Alzheimer's Disease Clinical Trials Database - Free Access to 801 Studies
Access comprehensive clinical trial information for Alzheimer's Disease through Pure Global AI's free database. This collection includes 801 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 58 trials are actively recruiting participants.
Research for Alzheimer's Disease is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include GlaxoSmithKline and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab
Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)
Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil
[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection.
Theta Burst Stimulation for Mild to Moderate Alzheimer's disease.
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease
A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease
Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration
Untitled Trial
Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers
Effectiveness of a Combined Reminiscence Therapy, Coffee Therapy, and Activities of Daily Living Practice Intervention for Older People with Moderate-to-Severe Alzheimer's Disease: A Retrospective Time Series Study
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease
Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients.
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
Untitled Trial
Pure Global AI provides free access to 801 clinical trials studying Alzheimer's Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, Pfizer, Eli Lilly and Company, among others.